News
Supreme Court Narrows Active Inducement Claims in Vascepa Generic Drug Decision
August 6, 2026
In the long-standing litigation between Hikma Pharmaceuticals USA Inc. and Amarin Pharma, Inc., the Supreme Court unanimously held that “Amarin failed to state a claim for active inducement, so its complaint cannot withstand Hikma’s motion to dismiss.” This Supreme Court opinion reversed the Federal Circuit’s 2024 judgment, which was primarily related to issues surrounding Hikma’s... Read More
October 2, 2023
Delaware Chief Judge Connolly Credits Ivan Hofmann’s Commercial Success Testimony in a Pharmaceutical Patent Case Gleason IP was retained by multiple defendants in a patent infringement matter related to Taiho Pharmaceutical Co., Ltd. and Taiho Oncology, Inc.’s Lonsurf® (trifluridine and tipiracil) tablets. Lonsurf® tablets are a prescription medicine for stomach cancer (sometimes referred to... Read More
August 3, 2020
Recently the practice of establishing so called patent-thickets for biologic products has been questioned as a potentially abusive way of preventing biosimilar competition. In June 2020, the Honorable Judge Manish S. Shah in the United States District Court for the Northern District of Illinois Eastern Division issued a Memorandum Opinion and Order dismissing a class... Read More